Cancer Treatment News and Research

RSS

Scientists illuminate how blood cancer treatments can lead to therapy-related myeloid neoplasms

Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have illuminated how treatments for multiple myeloma and other aggressive blood cancers can lead to future malignancies, called therapy-related myeloid neoplasms (tMNs).

25 Jan 2023

Scientists reveal how genetic changes lead to differences in the size of cancer cells

Cancer cells can shrink or super-size themselves to survive drug treatment or other challenges within their environment, researchers have discovered.

25 Jan 2023

Targeting newly discovered signaling pathway could boost the potency of cancer therapeutics

Cells zealously protect the integrity of their genomes, because damage can lead to cancer or cell death. The genome - a cell's complete set of DNA - is most vulnerable while it is being duplicated before a cell divides. Cancer cells constantly are dividing, so their genomes are constantly in jeopardy.

24 Jan 2023

Chemotherapy schedule affects treatment outcomes in female DLBCL patients

Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword. While the drugs are highly effective at killing cancer cells, they are also notorious for killing healthy cells in the body.

24 Jan 2023

Geographic region associated with risk of breast cancer treatment delays for Black and non-Black patients

Study finds that Black patients and patients living in certain regions experience greater delays.

23 Jan 2023

RUSH aims to deliver top-quality care with plans for new cancer treatment center in Lisle

RUSH is advancing its mission of delivering seamless, top-quality care with plans for a new cancer treatment center in Lisle, Illinois, that will strengthen the health of the community by increasing access to care where and when patients need it most.

20 Jan 2023

Study reveals how most-resistant pancreatic cancer cells defy treatment

Pancreatic cancer is the third deadliest cancer in the United States, after lung and colorectal, though far less common.

19 Jan 2023

Researchers develop innovative STAb therapy for a type of leukemia

Researchers of the Hospital Universitario 12 de Octubre in Madrid and the Josep Carreras Leukaemia Research Institute have developed a cell therapy for a type of leukemia which currently has very few treatment options.

16 Jan 2023

New drug combination may offer better prognosis for children diagnosed with deadly brain cancer

Researchers at the University of Colorado Anschutz Medical Campus have discovered a drug combination that may offer a better prognosis for children diagnosed with MYC amplified Medulloblastoma, an often deadly form of brain cancer.

13 Jan 2023

Bacteria play specific roles in cancer

In a recent article published in the journal Immunity, the authors discussed the findings from a 2022 study by Galeano Niño et al., which reported that microbiota associated with tumors form micro-niches and play a role in epithelial and immune mediations of cancer.

12 Jan 2023

Silencing the immune evasion gene enhances cancer cells' susceptibility to immunotherapy

Immune checkpoint inhibitors are important medications that boost the immune system's response against various cancers, but some patients' cancer cells are unaffected by the drugs or develop resistance during treatment.

12 Jan 2023

How might healthcare transform in the next 50 years?

A new study published in Futures highlighted key factors likely to influence the evolution of medicine over the next 50 years. These factors included wellness technologies, data-driven personalization, and climate change.

12 Jan 2023

Immunotherapy prior to surgery strikingly effective for patients with colorectal cancer

New research in the January 2023 issue of JNCCN - Journal of the National Comprehensive Cancer Network finds that immunotherapy from immune checkpoint (PD-1) inhibitors prior to surgery was strikingly effective for patients with localized mismatch repair-deficient or microsatellite instability-high (dMMR/MSI-H) colorectal cancer (CRC).

12 Jan 2023

New genetic test could guide the treatment of ovarian cancer

Researchers have developed an optimized genetic test for ovarian cancer, which helps accurately target an effective but expensive medication.

11 Jan 2023

Anticancer drugs offer new hope for treatment of sepsis

Research led by the IGC reveals how these drugs limit inflammation, positioning them as potential treatments for sepsis.

10 Jan 2023

Rare protein variant may hold the key to boosting effectiveness of breast cancer treatment

A rare variant of a protein present in nearly all human cells may hold the key to improving the effectiveness of breast cancer treatment, according to new research funded by Breast Cancer Now.

10 Jan 2023

Brief tele-cognitive behavioral therapy for head and neck cancer survivors with body-image distress shows promising results

Talking, smiling, eating together – these are all social activities that are inherent to the human experience. But for some head and neck cancer survivors, they are dreaded tasks.

6 Jan 2023

Immune system B-cells may be better in predicting HER2-positive breast cancer treatment response

Researchers at UNC Lineberger Comprehensive Cancer Center and colleagues have found that measuring activation of immune-system B cells may be better than measuring either T-cell activation or the total number of immune cells in and around a tumor, called tumor-infiltrating lymphocytes (TILs), in predicting whether HER2-positive breast cancer responds to treatment.

5 Jan 2023

Precise 3D imaging can help measure radiation during cancer treatment

Radiation, used to treat half of all cancer patients, can be measured during treatment for the first time with precise 3D imaging developed at the University of Michigan.

3 Jan 2023

NCI-led clinical trial results in the first approval of a treatment for advanced alveolar soft part sarcoma

A clinical trial led by the National Cancer Institute (NCI), part of the National Institutes of Health, has resulted in the first approval of a treatment for advanced alveolar soft part sarcoma (ASPS).

28 Dec 2022

Cancer Treatment News and Research

Scientists illuminate how blood cancer treatments can lead to therapy-related myeloid neoplasms

Scientists reveal how genetic changes lead to differences in the size of cancer cells

Targeting newly discovered signaling pathway could boost the potency of cancer therapeutics

Chemotherapy schedule affects treatment outcomes in female DLBCL patients

Geographic region associated with risk of breast cancer treatment delays for Black and non-Black patients

RUSH aims to deliver top-quality care with plans for new cancer treatment center in Lisle

Study reveals how most-resistant pancreatic cancer cells defy treatment

Researchers develop innovative STAb therapy for a type of leukemia

New drug combination may offer better prognosis for children diagnosed with deadly brain cancer

Bacteria play specific roles in cancer

Silencing the immune evasion gene enhances cancer cells' susceptibility to immunotherapy

How might healthcare transform in the next 50 years?

Immunotherapy prior to surgery strikingly effective for patients with colorectal cancer

New genetic test could guide the treatment of ovarian cancer

Anticancer drugs offer new hope for treatment of sepsis

Rare protein variant may hold the key to boosting effectiveness of breast cancer treatment

Brief tele-cognitive behavioral therapy for head and neck cancer survivors with body-image distress shows promising results

Immune system B-cells may be better in predicting HER2-positive breast cancer treatment response

Precise 3D imaging can help measure radiation during cancer treatment

NCI-led clinical trial results in the first approval of a treatment for advanced alveolar soft part sarcoma

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News